Is the 'Golden Age' of antiobotics in our rearview mirror?

Caitlin Wilson | | Health Exec | Precision Medicine

Some experts are now saying the “golden age of antibiotics” is behind us, according to the Los Angeles Times. The ability to stop a bacterial infection in its tracks is a thing of the past, because more and more antibiotic-resistant gene markers are showing up in bacteria in the U.S.

One particularly worrying sign is that a colistin-resistant gene was found in the E. coli bacteria from an infected woman in the U.S. That gene could move to other similar (or even not similar) bacteria and spread, infecting more people without the ability to treat them.

Check out the story in the Los Angeles Times for more info on how we got here and what comes next.  

A 'slow catastrophe' unfolds as the golden age of antibiotics comes to an end

Caitlin Wilson,

Senior Writer

As a Senior Writer at TriMed Media Group, Caitlin covers breaking news across several facets of the healthcare industry for all of TriMed's brands.

Related Content

Pitching the business case for 3D printing labs in radiology
FDA issues first-ever clearance for OTC oximeter
Augmented reality company secures $15M in funding from Cleveland Clinic, Mayo, GE Healthcare and more
Merck to acquire Prometheus Biosciences for $10.8B
Johnson & Johnson scraps RSV vaccine after trial
Intermountain Health launches new biotech company

Around the web

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Cardiovascular Business
Cardiology groups cheer new bill that would improve access to Medicare claims data

If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup